Prescription Drug Benefits and Survival in Myeloma Among Medicare Beneficiaries
A study which investigates the relationship between prescription drug coverage, receipt of active myeloma therapy, and overall survival (OS) among Medicare beneficiaries with multiple myeloma is presented. Association between prescription drug coverage status and OS was the primary outcome measure o...
Saved in:
| Published in: | Journal of clinical outcomes management Vol. 25; no. 9; p. 402 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
Wayne
Turner White Communications Inc
01-11-2018
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | A study which investigates the relationship between prescription drug coverage, receipt of active myeloma therapy, and overall survival (OS) among Medicare beneficiaries with multiple myeloma is presented. Association between prescription drug coverage status and OS was the primary outcome measure of interest. Changing demographics, increasing oral therapy options, and patient convenience demand attention to providing prescription drug coverage to all Medicare beneficiaries. This study lends support to that demand. |
|---|---|
| ISSN: | 1079-6533 1938-1336 |